These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25360242)

  • 1. A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections.
    Das AK; Malik A; Haddad PM
    Ther Adv Psychopharmacol; 2014 Oct; 4(5):179-85. PubMed ID: 25360242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
    Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
    J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives.
    Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):14S-22S. PubMed ID: 23945063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.
    Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):23S-9S. PubMed ID: 23945064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia.
    Kane JM; McEvoy JP; Correll CU; Llorca PM
    CNS Drugs; 2021 Nov; 35(11):1189-1205. PubMed ID: 34636025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive views on antipsychotic long-acting injections: results of a survey of community patients prescribed antipsychotics.
    Mace S; Chak O; Punny S; Sedough-Abbasian D; Vegad C; Taylor DM
    Ther Adv Psychopharmacol; 2019; 9():2045125319860977. PubMed ID: 31321027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan.
    Sugawara N; Kudo S; Ishioka M; Sato Y; Kubo K; Yasui-Furukori N
    Neuropsychiatr Dis Treat; 2019; 15():205-211. PubMed ID: 30666117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The knowledge and attitudes of psychiatrists towards antipsychotic long-acting injections in Nigeria.
    James BO; Omoaregba JO; Okonoda KM; Otefe EU; Patel MX
    Ther Adv Psychopharmacol; 2012 Oct; 2(5):169-77. PubMed ID: 23983972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
    Correll CU; Citrome L; Haddad PM; Lauriello J; Olfson M; Calloway SM; Kane JM
    J Clin Psychiatry; 2016; 77(suppl 3):1-24. PubMed ID: 27732772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional comparison of first-generation antipsychotic long-acting injections vs risperidone long-acting injection: patient-rated attitudes, satisfaction and tolerability.
    Singh SM; Haddad PM; Husain N; Heaney E; Tomenson B; Chaudhry IB
    Ther Adv Psychopharmacol; 2016 Jun; 6(3):162-71. PubMed ID: 27354904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitude and influencing factors of patients with schizophrenia toward long-acting injections: A community-based cross-sectional investigation in China.
    Sun Y; Tong J; Feng Y; Fang H; Jiang T; Zhao L; Wang Q; Yang Y
    Front Public Health; 2022; 10():951544. PubMed ID: 36299738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia.
    Potkin S; Bera R; Zubek D; Lau G
    BMC Psychiatry; 2013 Oct; 13():261. PubMed ID: 24131801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging long-acting antipsychotics for the treatment of schizophrenia.
    de Filippis R; De Fazio P; Gaetano R; Steardo L; Cedro C; Bruno A; Zoccali RA; Muscatello MRA
    Expert Opin Drug Saf; 2021 Jul; 20(7):771-790. PubMed ID: 33775184
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland.
    Reymann S; Schoretsanitis G; Egger ST; Mohonko A; Kirschner M; Vetter S; Homan P; Seifritz E; Burrer A
    J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
    Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.
    Verdoux H; Pambrun E; Tournier M; Bezin J; Pariente A
    Schizophr Res; 2016 Dec; 178(1-3):58-63. PubMed ID: 27624680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.
    Nielsen J; Jensen SO; Friis RB; Valentin JB; Correll CU
    Schizophr Bull; 2015 May; 41(3):627-36. PubMed ID: 25180312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of European physicians towards the use of long-acting injectable antipsychotics.
    Patel MX; Bent-Ennakhil N; Sapin C; di Nicola S; Loze JY; Nylander AG; Heres S
    BMC Psychiatry; 2020 Mar; 20(1):123. PubMed ID: 32169077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge.
    Doshi JA; Pettit AR; Stoddard JJ; Zummo J; Marcus SC
    J Clin Psychopharmacol; 2015 Aug; 35(4):442-6. PubMed ID: 26075492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review.
    Waddell L; Taylor M
    Br J Psychiatry Suppl; 2009 Nov; 52():S43-50. PubMed ID: 19880916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.